Therapeutic implications of osteoprotegerin
<p>Abstract</p> <p>Osteoprotegerin (OPG), a member of the tumor necrosis factor (TNF) receptor superfamily, contributes determinatively to the bone remodeling as well as to the pathogenetic mechanism of bone malignancies and disorders of mineral metabolism. There is additional evid...
Main Authors: | Karalaki Maria, Fili Sofia, Schaller Bernhard |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-09-01
|
Series: | Cancer Cell International |
Online Access: | http://www.cancerci.com/content/9/1/26 |
Similar Items
-
Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages.
by: Itonaga, I, et al.
Published: (2000) -
Osteoprotegerin genetic polymorphisms and their influence on therapeutic response to ibandronate in postmenopausal osteoporotic females.
by: Saba Tariq, et al.
Published: (2023-01-01) -
Osteoprotegerin genetic polymorphisms and their influence on therapeutic response to ibandronate in postmenopausal osteoporotic females
by: Saba Tariq, et al.
Published: (2023-01-01) -
Role of osteoprotegerin (OPG) in cancer.
by: Holen, I, et al.
Published: (2006) -
A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension
by: Nadine D. Arnold, et al.
Published: (2019-11-01)